| Kevin B Jones, MD | |
|
3308 Samson Way Ste 102, Bellevue, NE 68123 | |
| (402) 291-3373 | |
| Not Available |
| Full Name | Kevin B Jones |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 3308 Samson Way Ste 102, Bellevue, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316084098 | NPI | - | NPPES |
| 18223 | Other | NE | STATE LIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18223 (Nebraska) | Primary |
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598811069 PECOS PAC ID: 1951210418 Enrollment ID: O20040116000817 |
News Archive
A multi-institutional study led by a Massachusetts General Hospital investigator finds significant racial disparities in the risk that patients being treated for gout will develop a serious, sometimes life-threatening adverse reaction to the most commonly prescribed medication. The increased risk closely correlates with the frequency of a gene variant previously associated with that adverse reaction, supporting recommendations to screen for that variant in patients from those populations.
Physicians-in-training are highly vulnerable to making medical errors that stem from teamwork breakdowns, especially a lack of supervision by experienced staff, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
A leading clinical research center in Austin has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.
Huntington's disease (HD) is characterized by ongoing destruction of specific neurons within the brain. It affects a person's ability to walk, talk, and think - leading to involuntary movement and loss of muscle co-ordination. New research published in BioMed Central's open access journal Molecular Neurodegeneration shows that the RyanR inhibitor Dantrolene is able to reduce the severity of walking and balance problems in a mouse model of HD.
Intradigm Corporation, has announced achievement of prophylactic and therapeutic effects of siRNA (small interfering RNA) inhibitors of SARS-CoV in non-human primate cells. The results are published in the June 2004 issue of Antiviral Therapy (International Medical Press).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin B Jones, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: () - | Kevin B Jones, MD 3308 Samson Way Ste 102, Bellevue, NE 68123 Ph: (402) 291-3373 |
News Archive
A multi-institutional study led by a Massachusetts General Hospital investigator finds significant racial disparities in the risk that patients being treated for gout will develop a serious, sometimes life-threatening adverse reaction to the most commonly prescribed medication. The increased risk closely correlates with the frequency of a gene variant previously associated with that adverse reaction, supporting recommendations to screen for that variant in patients from those populations.
Physicians-in-training are highly vulnerable to making medical errors that stem from teamwork breakdowns, especially a lack of supervision by experienced staff, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
A leading clinical research center in Austin has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.
Huntington's disease (HD) is characterized by ongoing destruction of specific neurons within the brain. It affects a person's ability to walk, talk, and think - leading to involuntary movement and loss of muscle co-ordination. New research published in BioMed Central's open access journal Molecular Neurodegeneration shows that the RyanR inhibitor Dantrolene is able to reduce the severity of walking and balance problems in a mouse model of HD.
Intradigm Corporation, has announced achievement of prophylactic and therapeutic effects of siRNA (small interfering RNA) inhibitors of SARS-CoV in non-human primate cells. The results are published in the June 2004 issue of Antiviral Therapy (International Medical Press).
› Verified 8 days ago
Dr. James I Wax, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2206 Longo Drive Suite 210, Bellevue, NE 68005 Phone: 402-292-5594 Fax: 402-292-5832 | |
Dr. Joseph S Miller, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1902 Harlan Dr, Bellevue, NE 68005 Phone: 402-682-4165 Fax: 402-934-2291 | |
Dr. Jeremy C King, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 Bellevue Medical Center Dr Ste 200, Bellevue, NE 68123 Phone: 402-595-2275 Fax: 402-595-1970 | |
Holly Lynn Groteluschen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2510 Bellevue Medical Center Dr Ste 200, Bellevue, NE 68123 Phone: 402-595-2275 | |
Brian J Finley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 Bellevue Medical Center Dr, Ste 145a, Bellevue, NE 68123 Phone: 402-779-7207 Fax: 402-779-7210 | |
Dr. Khalil John Burhan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3308 Samson Way, Bellevue, NE 68123 Phone: 402-827-1577 Fax: 402-898-3134 |